Thema
615
1.307
che
1.302
A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d)
1.248
C07K: Peptides (peptides containing β-lactam rings c07d;cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d;ergot alkaloids of the cyclic peptide type c07d0519020000; single cell proteins, enzymes c12n;genetic engineering processes for obtaining peptides c12n0015000000)
798
A61P: Specific therapeutic activity of chemical compounds or medicinal preparations
611
bio
498
C12N: Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media (microbiological testing media c12q0001000000)
403
Journal Article
295
tec
212
G01N: Investigating or analysing materials by determining their chemical or physical properties (measuring or testing processes other than immunoassay, involving enzymes or microorganisms c12m, c12q)
208
Research Support, Non-U.S. Gov't
137
C12Q: Measuring or testing processes involving enzymes, nucleic acids or microorganisms (immunoassay g01n0033530000); compositions or test papers therefor; processes of preparing such compositions; condition-responsive control in microbiological or enzymological processes
134
G16B: Bioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology
52
RNA, Messenger
44
C07H: Sugars; derivatives thereof; nucleosides; nucleotides; nucleic acids (derivatives of aldonic or saccharic acids c07c, c07d;aldonic acids, saccharic acids c07c0059105000, c07c0059285000;cyanohydrins c07c0255160000;glycals c07d;compounds of unknown constitution c07g;polysaccharides, derivatives thereof c08b;dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification c12n0015000000;sugar industry c13)
38
Antigens, Neoplasm
37
Cancer Vaccines
37
Biology
32
C12P: Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture
31
Review
29
570
27
Antibodies, Viral
27
COVID-19 Vaccines
27
RNA
26
BNT162 Vaccine
24
Antibodies, Neutralizing
23
Breast cancer
21
63231-63-0
19
N38TVC63NU
19
Randomized Controlled Trial
19
Biomarkers, Tumor
18
Spike Glycoprotein, Coronavirus
17
Clinical Trial, Phase I
16
spike protein, SARS-CoV-2
15
Membrane Proteins
14
RNA vaccine
14
SARS-CoV-2
14
Antibodies
13
Claudins
13
Immunology
13
RT-qPCR
13
Antigens
12
COVID-19
12
Clinical Trial, Phase II
11
Comparative Study
11
Immunotherapy
11
Vaccines, Synthetic
11
immunotherapy
11
Antibodies, Monoclonal
10
B82Y: Specific uses or applications of nanostructures; measurement or analysis of nanostructures; manufacture or treatment of nanostructures
10
mehr ...